GlassScriptPhysician profile
Ronnen Abramov
NPI 1508987892
$1,323.20
in general payments reported to CMS, 2019-2025
12 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $16.44 · 2021: $128 · 2022: $225 · 2023: $406 · 2024: $42.91 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $512.65 | 2020-2025 | Proclaim, Octrode, Eterna |
| Nevro Corp. | $255.47 | 2019-2023 | Senza |
| Medtronic, INC. | $135.15 | 2021-2025 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $118.23 | 2019-2025 | Sprint Pns System |
| Si-Bone, INC. | $99.12 | 2019-2023 | |
| Boston Scientific Corporation | $66.76 | 2019-2025 | General - Pain Management |
| Globus Medical, INC. | $36.18 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $31.26 | 2025 | Belbuca |
| Pfizer INC. | $29.46 | 2019 | |
| Medtronic USA, INC. | $14.87 | 2019 | |
| Mdd US Operations, LLC | $12.91 | 2019 | |
| Virtus Pharmaceuticals LLC | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronnen Abramov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.